Hypera S.A. (HYPE3.SA)
BRL 16.8
(-5.46%)
BRL 16.8
(-5.46%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.9 Billion BRL | -3.96% |
| 2022 | 2.79 Billion BRL | 29.57% |
| 2021 | 2.17 Billion BRL | 42.77% |
| 2020 | 1.54 Billion BRL | 19.74% |
| 2019 | 1.26 Billion BRL | -7.51% |
| 2018 | 1.35 Billion BRL | 0.2% |
| 2017 | 1.34 Billion BRL | 12.77% |
| 2016 | 1.13 Billion BRL | 7.05% |
| 2015 | 992.47 Million BRL | -6.78% |
| 2014 | 948.98 Million BRL | 9.92% |
| 2013 | 1.1 Billion BRL | -0.44% |
| 2012 | 869.59 Million BRL | 38.57% |
| 2011 | 491.18 Million BRL | -0.74% |
| 2010 | 765.14 Million BRL | 46.15% |
| 2009 | 525.48 Million BRL | 76.64% |
| 2008 | 67.71 Million BRL | 37.12% |
| 2007 | 228.4 Million BRL | 472.07% |
| 2006 | 42.35 Million BRL | -17.68% |
| 2005 | 48.5 Million BRL | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 630.32 Million BRL | 16.75% |
| 2024 Q2 | 714.88 Million BRL | 11.55% |
| 2023 Q3 | 838.39 Million BRL | 1.74% |
| 2023 Q1 | 623.96 Million BRL | -20.92% |
| 2023 FY | - BRL | -3.96% |
| 2023 Q2 | 824.06 Million BRL | 32.07% |
| 2023 Q4 | 588.64 Million BRL | -29.79% |
| 2022 Q1 | 537.76 Million BRL | -10.63% |
| 2022 Q2 | 721.07 Million BRL | 34.09% |
| 2022 Q3 | 763.86 Million BRL | 5.93% |
| 2022 Q4 | 789.03 Million BRL | 3.29% |
| 2022 FY | - BRL | 29.57% |
| 2021 Q3 | 602.46 Million BRL | 0.36% |
| 2021 FY | - BRL | 42.77% |
| 2021 Q1 | 367.31 Million BRL | 6.49% |
| 2021 Q2 | 600.31 Million BRL | 63.43% |
| 2021 Q4 | 601.71 Million BRL | -0.12% |
| 2020 FY | - BRL | 19.74% |
| 2020 Q2 | 481.66 Million BRL | 74.35% |
| 2020 Q1 | 276.27 Million BRL | 14.42% |
| 2020 Q4 | 344.92 Million BRL | -16.03% |
| 2020 Q3 | 410.74 Million BRL | -14.72% |
| 2019 Q4 | 241.45 Million BRL | -24.08% |
| 2019 Q1 | 411.79 Million BRL | 19.37% |
| 2019 Q3 | 318.03 Million BRL | 6.7% |
| 2019 Q2 | 298.05 Million BRL | -27.62% |
| 2019 FY | - BRL | -7.51% |
| 2018 Q3 | 301.31 Million BRL | -13.5% |
| 2018 Q1 | 377.84 Million BRL | 29.53% |
| 2018 FY | - BRL | 0.2% |
| 2018 Q4 | 344.95 Million BRL | 14.49% |
| 2018 Q2 | 348.33 Million BRL | -7.81% |
| 2017 Q3 | 317.2 Million BRL | -12.67% |
| 2017 Q2 | 363.23 Million BRL | -8.69% |
| 2017 Q1 | 397.8 Million BRL | 144.87% |
| 2017 FY | - BRL | 12.77% |
| 2017 Q4 | 291.7 Million BRL | -8.04% |
| 2016 Q3 | 300.17 Million BRL | -15.8% |
| 2016 FY | - BRL | 7.05% |
| 2016 Q4 | 162.45 Million BRL | -45.88% |
| 2016 Q2 | 356.49 Million BRL | -9.86% |
| 2016 Q1 | 395.49 Million BRL | 77.34% |
| 2015 Q2 | 310.54 Million BRL | 0.65% |
| 2015 Q3 | 292.4 Million BRL | -5.84% |
| 2015 Q4 | 223.01 Million BRL | -23.73% |
| 2015 FY | - BRL | -6.78% |
| 2015 Q1 | 308.55 Million BRL | 9.36% |
| 2014 Q1 | 285.19 Million BRL | -4.94% |
| 2014 Q4 | 282.13 Million BRL | -13.05% |
| 2014 Q3 | 324.49 Million BRL | 2.74% |
| 2014 FY | - BRL | 9.92% |
| 2014 Q2 | 315.83 Million BRL | 10.74% |
| 2013 Q3 | 285.09 Million BRL | -3.74% |
| 2013 Q2 | 296.15 Million BRL | 18.07% |
| 2013 Q1 | 250.83 Million BRL | 10.22% |
| 2013 FY | - BRL | -0.44% |
| 2013 Q4 | 300.03 Million BRL | 5.24% |
| 2012 Q4 | 227.57 Million BRL | 0.33% |
| 2012 Q1 | 236.36 Million BRL | 41.71% |
| 2012 Q2 | 281.88 Million BRL | 19.26% |
| 2012 Q3 | 226.83 Million BRL | -19.53% |
| 2012 FY | - BRL | 38.57% |
| 2011 Q4 | 166.78 Million BRL | 11.69% |
| 2011 Q1 | 216.43 Million BRL | -11.18% |
| 2011 FY | - BRL | -0.74% |
| 2011 Q2 | 269.99 Million BRL | 24.75% |
| 2011 Q3 | 149.33 Million BRL | -44.69% |
| 2010 FY | - BRL | 46.15% |
| 2010 Q3 | 204.8 Million BRL | 17.02% |
| 2010 Q2 | 175.01 Million BRL | 24.11% |
| 2010 Q4 | 243.66 Million BRL | 18.98% |
| 2010 Q1 | 141.01 Million BRL | -14.39% |
| 2009 Q2 | 214.14 Million BRL | 138.27% |
| 2009 Q1 | 89.87 Million BRL | 0.0% |
| 2009 FY | - BRL | 76.64% |
| 2009 Q4 | 164.72 Million BRL | 3.23% |
| 2009 Q3 | 159.56 Million BRL | -25.49% |
| 2008 FY | - BRL | 37.12% |
| 2007 FY | - BRL | 472.07% |
| 2006 FY | - BRL | -17.68% |
| 2005 FY | - BRL | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Blau Farmacêutica S.A. | 410.54 Million BRL | -608.474% |